PROFILASSI DELLA NEFROLITIASI CALCICA RECIDIVANTE (NCR) CON TIAZIDICI. VALUTAZIONI CLINICO-METABOLICHE

Translated title of the contribution: Prophylaxis of recurring calcium nephrolithiasis with thiazide: Clinical and metabolic evaluation

A. Aroldi, A. Antonacci, G. Bonforte, M. Surian, E. Macchi, A. Cantaluppi, G. Graziani

Research output: Contribution to journalArticlepeer-review

Abstract

Clinical and metabolic effects of long-term Thiazide therapy were evaluated in 73 patients with HRSF: 34 with Calcium Renal Leak, 18 with Intestinal Hyperabsorption, 12 with Renal Phosphate leak, and 9 with Resorptive Hypercalciuria. These 73 patients passed 576 stones in the 2304 months/patient before treatment while during the 689 months/patients of therapy, they passed 4 stones (p4/GFR decreased from 2.9 ± 0.4 to 2.0 ± 0.6 (

Translated title of the contributionProphylaxis of recurring calcium nephrolithiasis with thiazide: Clinical and metabolic evaluation
Original languageItalian
Pages (from-to)315-319
Number of pages5
JournalMinerva Nefrologica
Volume26
Issue number3
Publication statusPublished - 1979

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Prophylaxis of recurring calcium nephrolithiasis with thiazide: Clinical and metabolic evaluation'. Together they form a unique fingerprint.

Cite this